Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Transferase other than ribonuclease
Patent
1996-11-21
1999-09-21
Wax, Robert A.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Transferase other than ribonuclease
C12N 910
Patent
active
059553375
DESCRIPTION:
BRIEF SUMMARY
BACKGROUND OF THE INVENTION
A DNA molecule containing a gene which reverses a mutant phenotype of a strain of Saccharomyces cerevisiae is isolated and purified. The gene is GLS1 (glucan synthesis gene 1). GLS1 encodes a subunit of 1,3-.beta.-D glucan synthase. The protein encoded by GLS1 represents a target for drug therapy for fungal disease. The invention includes homologues of GLS1 is isolated from other fungi, such as Aspergillus fumigatus, Candida albicans, Schizosaccharmomyces pombe and Phytophthora infestans.
Understanding the mode of action of therapeutic compounds requires a variety of experimental approaches. One approach involves the isolation of organisms resistant or sensitive to test compounds. Such organisms may be used to isolate genes encoding the drug targets.
The fungal cell wall is a complex structure composed of a number of polymers: chitin, .alpha.- and .beta.-glucans, and mannoproteins. The fungal cell wall is involved in a variety of vital cellular processes: vegetative growth, morphogenesis, uptake and secretion of macromolecules and protection against osmotic changes are affected by changes in the composition and integrity of the cell wall. Antifungal compounds which act via the inhibition of cell wall synthesis (a process essential to fungi and absent from mammalian cells) may have high fungicidal activity and low toxicity to mammalian cells.
One class of .beta.-glucan inhibitors is comprised of lipopeptide antibiotics such as aculeacin A, echinocandin B and the pneumocandins. These compounds are cyclic hexapeptides that contain a non-polar fatty acid side chain. Echinocandins are fungicidal because they inhibit synthesis of 1,3-.beta.-D glucan, which disrupts the integrity of the cell wall and causes lysis of yeast cells. In vitro echinocandins inhibit polymerization of glucose into 1,3-.beta.-D glucan.
Another class of .beta.-glucan synthesis inhibitors comprises the papulacandins and chaetiacandin. These compounds contain a glycoside component connected to an aromatic ring system and two long chain fatty acids. These compounds have the same mode of action as the echinocandins.
It has been shown that Pneumocystis carinii has .beta.-glucan in the wall of its cyst form (Matsumoto, Y., et al., 1989, J. Protozool. 36: 21S-22S). Inhibitors of .beta.-glucan synthesis, such as papulacandins and echinocandins, may be useful in the treatment of P. carinii infections. In a rat model of P. carinii pneumonia, L-671,329 (an echinocandin) and L-687,781 (a papulacandin) were both effective in reducing the number of cysts in the lungs of infected rats (D. M. Schmatz et al., 1990, PNAS 87: 5950-5954). These results suggest that .beta.-glucan synthesis is a target for the identification of therapeutics useful in the treatment of P. carinii infections.
There have been a number of efforts to isolate drug-resistant yeast strains affected in .beta.-glucan synthesis. The mutants that have been isolated include acul (Mason, M. M., et al., 1989, Cold Spring Harbor Laboratory, Abstract #154), and pap1 (Duran, A., et al., 1992, Profiles in Biotechnology (T. G. Villa and J. Abalde, Eds.) Serivicio de Publicaciones, Universidad de Santiago, Spain. pp. 221-232).
In the present work a more potent echinocandin (L-733,560) was used as a selective agent to isolate mutant strains specifically affected in glucan synthesis. One mutant (strain MS14) is echinocandin-resistant and is also supersensitive to the chitin synthase inhibitor nikkomycin Z. The mutation in MS14 maps to the FKS1 gene and is designated fks1-4. Another mutant (strain MS1) is resistant to echinocandins and supersensitive to both papulacandin and rapamycin. Strain MS1 was used to clone the GLS1 gene.
SUMMARY OF THE INVENTION
A DNA molecule encoding a protein involved in biosynthesis of 1,3-.beta.-D glucan (GLS1) is identified, cloned, expressed and used in assays to screen for antifungal compounds.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1. Segregation pattern (2:2) of meiotic products indicating single gene mutations conferring resistant t
REFERENCES:
patent: 5250436 (1993-10-01), James et al.
Spencer et al. (Jan. 1997) Interleukin-11 induces rapid PKC activation and cytosolic to particulate translocation of alpha and beta PKC isoforms in human erythroleukemia K562 cells. Biochem. Biophys. Res. Commun. 232: 61-64. subjects with schizophrenia: methodological aspects. Neuropharmacology 36(6): 779-786.
Brotz et al. (Jan. 1997) The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Eur. J. Biochem. 246: 193-199.
Lamura et al. (Jan. 1997) Compartmentalisation and characteristics of a Ca2+-dependent phospholipase A2 in human colon mucosa. Biochemical Pharmacology 53: 1323-1332. Methods in Enzymology 182: 499-520.
Breuder, et al., "Calcineurin is essential in cyclosporinA- and FK506-sensitive yeast strains", Proc. Natl. Acad. Sci., USA, vol. 91. pp. 5372-5376, Jun. 1994.
Koonin, et al., "Yeast chromosome III: new gene functions", The EMBO Journal, vol. 13, No. 3, pp. 493-509, 1994.
Hong, et al., "Cloning and Characterization of JNR4, a Yeast Gene Involved in (1,3)-B-Glucan Synthesis", Mol. and Cell. Biol., vol. 14, No. 2, pp. 1017-1025 (1994).
Frost, et al., "1 3-Beta Glucan Synthase from Saccharomyces-cerevisiae in titro activation by beta lactoglobulin . . . ", Curr. Microl., vol. 24, pp. 295-300 (1992).
Cerenius et al. (Jan. 1984) Isolation and proberties of beta-glucan synthetase from the aquatic fungus, Aphanomyces astaci, Physiol. Plant 60: 247-252.
Ngo et al. (Jan. 1994) Computational Complexity, Protein Structure Prediction and the Levinthal Paradox. In: The Protein Folding Problem and Tertiary Structure Prediction. Eds. Merz et al. Birkhauser, Boston, MA, 491-495. Enzymology 138:637-642.
Awald et al. (Jan. 1994) Purification of 1,3-beta-glucan synthase from Neurospora crassa by product entrapment. Experimental Mycology 17: 120-141.
Bulone et al. (Jan. 1993) Immunological characterization of 1,3-beta-D-glucan synthase from Saprolegnia monoica. Cellul.: Chem., Biochem. Mater. Aspects. Eds. Kennedy et al. London, United Kingdom, pp. 29-34.
Beauvais et al. (Jan. 1993) Characterization of the 1,3-beta-glucan synthase of Aspergillus fumigatus, Journal of General Microbiology 139: 3071-3078.
Kottutz et al. (Aug. 1990) 1,3-beta-glucan synthase in cell-free extracts from mycelium and protoplasts of Sclerotium glucanicum, Journal of General Microbiology 136: 1517-1523.
Nodet et al. (Jan. 1990) Congo red inhibits in vitro beta-glucan synthases of Saprolegnia, FEMS Microbiology Letters 69:225-228.
Fevre et al. (Jan. 1977) Beta-glucan synthetases from Saprolegnia monoica, Journal of General Microbiology 103: 297-306.
Morrow et al. (Jan. 1987) (1-3)-beta-D-glucan synthase from sugar beet. Plant Physiology 84: 565-567.
Aoki et al. (Jun. 1993) BU-4794F, A new beta-1,3-glucan synthase inhibitor, Journal of Antibiotics 46(6): 952-961.
Beaulieu et al. (May 1994) Characterization and Cilofungin Inhibition of Solubilized Aspergillus fumigatus (1,3)-beta-D-Glucan Synthase, Antimicrobial Agents and Chemotherapy 38 (5): 937-944.
Beaulieu et al. (Jan. 1993) Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-beta-D-glucan synthase, FEMS Micribiology Letters 108: 133-138.
Clemas Joseph A.
El-Sherbeini Mohammed
Coppola Joseph A.
Merck & Co. , Inc.
Stole Einar
Tribble Jack L.
Wax Robert A.
LandOfFree
DNA encoding GLS1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding GLS1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding GLS1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-79508